Pathogen Genomics Center, National Institute of Infectious Diseases, Shinjuku-ku, Tokyo, Japan.
Antimicrobial Resistance Research Center, National Institute of Infectious Diseases, Higashimurayama, Tokyo, Japan.
PLoS One. 2018 Dec 11;13(12):e0208976. doi: 10.1371/journal.pone.0208976. eCollection 2018.
Carbapenemase-producing Enterobacteriaceae (CPE) are a global concern because these bacteria are resistant to almost all β-lactams. Horizontal interspecies gene transfer via plasmid conjugation has increased the global dissemination of CPE. Recently, an Enterobacteriaceae strain positive for carbapenemase gene but showing a carbapenem-susceptible phenotype was identified, suggesting that these susceptible strains may be challenging to detect solely via antimicrobial susceptibility tests without molecular analysis. Here, we isolated a blaIMP-6 carbapenemase-gene positive but imipenem- and meropenem-susceptible Escherichia coli (ISMS-E) strain A56-1S (imipenem and meropenem minimum inhibitory concentration, ≤ 0.125 mg/L), from a human urine specimen in Japan. A56-1S was carbapenemase negative by the Carba NP test, suggesting that IMP-6 production was low or undetectable. Thus, to characterize the mechanism of this phenotype, a meropenem-resistant E. coli A56-1R strain was obtained using meropenem-selection. A56-1R was positive for carbapenemase production by the Carba NP test, and blaIMP-6 transcription in A56-1R was 53-fold higher than in A56-1S, indicating that blaIMP-6 in A56-1S is negatively regulated at the transcriptional level. Comparative genomic analysis between the two strains revealed that the alleviation of restriction of DNA (ardK) gene encoding a putative transcription factor is disrupted by the IS26 insertion in A56-1R. A cotransformation assay of ardK and the regulatory element upstream of blaIMP-6 showed repression of blaIMP-6 transcription, indicating that ArdK negatively modulates blaIMP-6 transcription. ArdK binding and affinity assays demonstrated that ArdK directly binds to the regulatory element upstream of blaIMP-6 with dissociation constant values comparable to those of general transcription factors. The IMP-6 carbapenemase showed low hydrolytic activity against imipenem, resulting in an imipenem-susceptible and meropenem-resistant (ISMR) phenotype (previously reported as a stealth phenotype). However, the low expression of IMP-6 in the A56-1S strain could be a typical characteristic of ISMS-E due to gene repression, indicating that conventional antimicrobial susceptibility tests might be unable to detect such strains even when using both imipenem and meropenem. Bacteria that exhibit the ISMS phenotype could play a potential role as undetectable reservoirs and might facilitate gene transfer to other organisms while avoiding detection.
产碳青霉烯酶肠杆菌科(CPE)是一个全球性的关注,因为这些细菌几乎对所有的β-内酰胺类药物都具有耐药性。通过质粒接合的水平种间基因转移增加了 CPE 的全球传播。最近,鉴定出一种产碳青霉烯酶基因但表现出碳青霉烯类药物敏感表型的肠杆菌科菌株,这表明这些敏感菌株仅通过不进行分子分析的抗菌药物敏感性试验可能难以检测到。在这里,我们从日本的一份人类尿液标本中分离出一株 blaIMP-6 碳青霉烯酶基因阳性但对亚胺培南和美罗培南敏感的大肠埃希菌(ISMS-E)菌株 A56-1S(亚胺培南和美罗培南最小抑菌浓度,≤0.125mg/L)。A56-1S 对 Carba NP 试验呈阴性,提示 IMP-6 产量较低或无法检测到。因此,为了阐明这种表型的机制,我们使用美罗培南选择获得了一株耐美罗培南的大肠埃希菌 A56-1R 菌株。A56-1R 对 Carba NP 试验产碳青霉烯酶呈阳性,且 A56-1R 中 blaIMP-6 的转录水平比 A56-1S 高 53 倍,表明 A56-1S 中的 blaIMP-6 在转录水平受到负调控。对两株菌的比较基因组分析表明,A56-1R 中的插入序列 IS26 破坏了编码假定转录因子的 DNA(ardK)基因的限制缓解。ardK 和 blaIMP-6 上游调控元件的共转化试验表明,ardK 抑制 blaIMP-6 的转录,表明 ArdK 负调控 blaIMP-6 的转录。ArdK 结合和亲和力试验表明,ArdK 直接与 blaIMP-6 上游的调控元件结合,解离常数与一般转录因子相当。IMP-6 碳青霉烯酶对亚胺培南的水解活性较低,导致亚胺培南敏感和美罗培南耐药(先前报道为隐匿表型)(ISMR)表型。然而,A56-1S 菌株中 IMP-6 的低表达可能是由于基因抑制,是 ISMS-E 的一个典型特征,表明即使同时使用亚胺培南和美罗培南,常规抗菌药物敏感性试验也可能无法检测到这种菌株。表现出 ISMS 表型的细菌可能作为不可检测的储库发挥作用,并可能在避免检测的情况下促进基因转移到其他生物体。